In Brief: Interleukin interference?
Interleukin interference?: Roche's IL-12 is being studied in clinical trials for advanced kidney cancer at Sloan-Kettering and the Cleveland Clinic, company says. Interleukin-12 was misidentified as interferon by "The Pink Sheet" in a story published June 19 ("The Pink Sheet" June 19, T&G-7)...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth